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Solid-state NMR spectroscopyPhospholamban (PLB) is a 52 amino acid integral membrane protein that interacts with the sarcoplasmic re-
ticulum Ca2+ ATPase (SERCA) and helps to regulate Ca2+ ﬂow. PLB inhibits SERCA impairing Ca2+ transloca-
tion. The inhibition can be relieved upon phosphorylation of PLB. The Arg9 to Cys (R9C) mutation is a loss of
function mutation with reduced inhibitory potency. The effect R9C PLB has on the membrane surface and the
hydrophobic region dynamics was investigated by 31P and 2H solid-state NMR spectroscopy in multilamellar
vesicles (MLVs). The 31P NMR spectra indicate that, like the phosphorylated PLB (P-PLB), the mutated
R9C-PLB protein has signiﬁcantly less interaction with the lipid bilayer headgroup when compared to
wild-type PLB (WT-PLB). Similar to P-PLB, R9C-PLB slightly decreases 31P T1 values in the lipid headgroup re-
gion. 2H SCD order parameters of 2H nuclei along the lipid acyl chain decrease less dramatically for R9C-PLB
and P-PLB when compared to WT-PLB. The results suggest that R9C-PLB interacts less with the membrane
surface and hydrophobic region than WT-PLB. Detachment of the cytoplasmic domain of R9C-PLB from the
membrane surface could be related to its loss of function.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Phospholamban is a 52 amino acidmembrane protein located in the
sarcoplasmic reticulum (SR). PLB interacts with and inhibits SERCA
which pumps Ca2+ from the cytoplasm into the SR [1–3]. Ca2+ translo-
cation into the SR induces heart muscle relaxation, while Ca2+ translo-
cation back to the cytoplasm induces heart muscle contraction [1]. The
inhibition of SERCA by PLB can be relieved either upon phosphorylation
of PLB at position 16 or 17 by protein kinase A or by elevated Ca2+ con-
centrations in the cytoplasm [4,5]. PLB has been shown to consist of four
domains: the cytoplasmic domain Ia (1–16), loop (17–22), domain Ib
(23–30) and the hydrophobic transmembrane domain (31–52) [6].
There has long been a debate on the cytoplasmic domain (domain Ia)
of PLB and whether it exists as an α-helix [7] or random coil [8], and if
it is anchored on the membrane surface [7], or sticking out into the cy-
toplasm as a bell-ﬂower assembly [9].
Current research indicates that the equilibrium exists between two
conformations of PLB [10–12]. The two conformations are the T and R
states. The T state exists at a low energy level with domain Ia folded as
an α-helix and attached to the membrane surface. The R state exists at
a higher energy level with domain Ia unfolded and dissociated from
the membrane surface [10,13]. Excellent work by the Veglia group
using solid-state NMR indicates that most of WT-PLB exist as the
T-state pentamer with the α-helical cytoplasmic domain laying on the
membrane surface [6,7]. Phosphorylation of PLB shifts the PLBigan).
l rights reserved.population from the T state to the R state or an intermediate T′ state
with a partially unfolded cytoplasmic domain [7,13–15]. Domain Ib has
a larger dynamic population than in the cytoplasmic domain [16]. It in-
serts into the membrane surface as an α-helix with unknown function
[17]. The transmembrane domain inserts into the membrane as an
α-helix forming a 13° angle with respect to the bilayer normal [7,18].
Wild-type PLB forms a pentamer with a Leu-zipper and three cysteines
in the transmembrane domain stabilizing the complex [7]. Small popula-
tions of PLB exist in amonomeric form,which is believed to interact with
and inhibit SERCA [1]. Thus, the pentamer form of PLB acts like an inac-
tive storage form, while themonomer is actively involved in SERCA inhi-
bition [6,7]. However, in vivo studies demonstrate that the monomeric
form of PLB can inhibit SERCA to the same extent asWT-PLB by reducing
SERCA-Ca2+ afﬁnity, but the monomer cannot regulate heart muscle re-
laxation rates as the pentamer form does [19].
The R9C-PLB mutation relieves inhibition function on SERCA as
P-PLB [20]. Individuals that carry this mutation tend to exhibit an en-
larged heart chamber and heart muscle contraction dysfunction which
can lead to heart failure [20]. In vivo studies using transgenic mice indi-
cate that the R9C-PLBmutation induces ﬁbrosis and enlargement of the
heart and nuclei in heart muscle cells [20]. Previous studies have shown
that the population of the R9C-PLB pentamer form is slightly more than
that of WT-PLB and R9C-PLB and cannot be phosphorylated efﬁciently
[21,22]. R9C-PLB has a similar afﬁnity to SERCA as WT-PLB and P-PLB
[21,23]. However, it is not clear why the R9C mutation induces loss of
function. Multiple mechanisms including oligomerization state, struc-
tural conformations, afﬁnity to SERCA and membrane interactions
could be involved.
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size, hydrophobicity and loss of stability or function or changes of con-
formation in a non-native lipid bilayer environment [24,25]. Solid-state
NMR spectroscopy is a powerful and robust way to probe the dynamic
and structural properties of membrane proteins [25–29]. By incorporat-
ing membrane proteins into lipids, the proteins are stabilized in their
native state retaining their functionality. Multilamellar vesicles, which
are composed of multi-layers of lipid bilayers, are commonly used to
study membrane proteins [30–32]. Membrane structure and dynamic
changes induced by the incorporation of proteins into the phospholipid
bilayer can be revealed using 31P solid-state NMR spectroscopy [33–35].
Also, 2H solid-state NMR spectroscopy of 2H labels along the lipid acyl
chain can be used to study the dynamics of the hydrophobic region of
the membrane [34–42]. In this study, interactions between lipid bilay-
ers and WT-PLB, P-PLB and R9C-PLB are investigated from the mem-
brane perspective using 31P and 2H solid-state NMR spectroscopy.
These experiments shed light onto the loss of functionality of the R9C
mutation from the membrane perspective.
2. Materials and methods
2.1. Materials
Phospholipids were purchased from Avanti Polar Lipids (Alabaster,
AL). 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) was dis-
solved in chloroform and stored at−20 °C before use. Triﬂuoroethanol
(TFE) and N-[2-hydroxyethyl]piperazine-N′-2-ethane sulfonic acid
(HEPES) were obtained from Sigma-Aldrich (St. Louis, MO). Ethylene-
diaminetetraacetic acid (EDTA) and sodium chloride (NaCl) were
obtained from Fisher Scientiﬁc (Pittsburgh, PA). Fmoc amino acids
were purchased from Applied Biosystems (Carlsbad, CA). All other pep-
tide synthesis and HPLC reagents and solvents were purchased from
VWR (San Dimas, CA).
2.2. Synthesis, puriﬁcation and characterization of WT-PLB and R9C-PLB
WT-PLB and R9C-PLB (sequences identiﬁed in humans) were syn-
thesized via Fmoc-based solid-phase peptide synthesis using a CEM
solid-phase peptide synthesizer. A General Electric (GE) AKTA puriﬁer
HPLCwas utilized to purify the peptides via reverse phase chromatogra-
phy on a C18 column. The puriﬁed peptides were lyophilized and char-
acterized by matrix-assisted laser desorption ionization time-of-ﬂight
(MALDI-TOF) mass spectrometry. The peptides were at least 95% pure.
2.3. NMR sample preparation
MLVs were prepared according to a protocol established by Rigby
and coworkers [40]. Lyophilized WT-PLB and R9C-PLB were dissolved
in a minimal amount of TFE. 35 mg of POPC was mixed with dissolved
peptides (4 mol% with respect to lipid) in a 12 × 75 mm test tube.
The solvent was removed by a steady stream of N2 gas and the tube
was placed in a vacuum dessicator overnight. The lipid peptide mix-
ture was rehydrated with 95 μL HEPES buffer (5 mM EDTA, 20 mM
NaCl and 30 mM HEPES at pH 7.0). Vesicles were formed in a warm
water bath at 45 °C for about 30 min using a vortexer and bath soni-
cation. The sample was transferred into a 4 mm NMR rotor. 2H NMR
samples were prepared with a lipid mixture consisting of 8 mg of
1-palmitoyl(d31)-2-oleoyl-sn-glycero-3-phosphocholine (POPC-d31)
and 27 mg of POPC.
2.4. Solid-state NMR spectroscopy
31P and 2H solid-state NMR spectra were acquired using a 500 MHz
WB Bruker Avance solid-state NMR spectrometer with a Bruker 4-mm
double resonance CP-MAS probe. For 31P data, the NMR spectrometer
was operated at 202.4 MHz and 1024 transients were averaged with100 Hz line broadening. Static powder pattern NMR spectra were col-
lected using the spin echo (90°-τ1-180°-τ1-acq) pulse sequence with
1H decoupling [35]. The recycle delaywas set to 5 s. All spectrawere ac-
quired at 25 °C. 31P T1 relaxationwas detected using an inversion recov-
ery (180°-τ-90°-acq) pulse sequence [43]. τwas set from 10 ms to 6 s.
The samplewas spun at 4 kHz at themagic angle. For T1measurements,
the spectrawere acquired at 25 °C, 35 °C, 45 °C and 55 °C for each sam-
ple and the samples were equilibrated at these temperatures for at least
10 min before spectral acquisition.
For 2H NMR experiments, the NMR spectrometer was operated at
76.77 MHz. The quadrupolar echo pulse sequence was employed
using quadrature detection with complete phase cycling of the pulse
pairs [40]. The 90° pulse length was 3 μs, the interpulse delay was
40 μs, and the recycle delay was 0.3 s. All spectra were acquired at
25 °C. The spectral width was 100 kHz and line broadening was set to
200 Hz. A total of 40,960 transients were averaged for each spectrum.
2.5. NMR data analysis
For 31P NMR simulations, the DMFIT software package was used
[44]. The spectra were ﬁt to a sum of a minimal number of lineshapes.
The 31P chemical shift anisotropy (CSA)was obtained from the simulat-
ed spectra. For T1 calculations, the data were ﬁt to a single-exponential
function: I(t) = I(0) − Aexp(−t/T1).
2H NMR spectrawere deconvoluted (dePaked) using the procedures
of McCabe andWassall [45,46]. The order parameters of each 2H on the
lipids were calculated from the quadrupolar splittings of the dePaked
2H NMR spectra according to the following expression [38,47]:
ΔνiQ ¼ 3=2 e2qQ=h
 
SiCD: ð1Þ
ΔνiQ is the quadrupolar splitting of a deuteron attached to the ith
carbon. e2qQ/h is the quadrupolar splitting constant (168 kHz for the
deuterons in C\2H bonds). SiCD is the chain order parameter of a deu-
teron attached to the ith carbon of the acyl chain of POPC. SCD of CD3
was calculated by multiplying by 3 to obtain the lipid CD3 terminal
order parameters according to the literature [30,48]. 2H nuclei at-
tached to the terminal methyl carbon was assigned as carbon number
15. The remaining 2H atoms were assigned in decreasing order along
the lipid acyl chain.
3. Results
3.1. 31P NMR spectroscopy of WT-PLB, P-PLB and R9C-PLB in phospholipid
bilayers
31P NMR spectra can provide unique structural and dynamic infor-
mation on the phospholipid headgroup region. Fig. 1 shows 31P NMR
spectra of MLVs of POPC with and without 4 mol%WT-PLB, P-PLB and
R9C-PLB. All static 31P NMR spectra show a characteristic axially sym-
metric powder pattern lineshape both with and without WT-PLB,
P-PLB and R9C-PLB. In Fig. 1, the addition of 4 mol% WT-PLB de-
creases the 31P CSA line width dramatically from 48(±0.2) ppm to
41(±0.2) ppm indicating an increase in 31P lipid membrane surface
dynamics. The addition of P-PLB and R9C-PLB has relatively moderate
effects on the 31P CSA width by decreasing it to 44(±0.2) ppm and
43(±0.2) ppm (Fig. 1). The results suggest that WT-PLB perturbs
the membrane surface head group region more when compared to
P-PLB or R9C-PLB. Also, the 31P NMR data suggest that P-PLB and
R9C-PLB may interact with the membrane surface in a similar way
and associate less with the membrane surface than WT-PLB. The 31P
NMR data were collected in the liquid-crystalline phase at 25 °C,
and the 31P chemical shift anisotropy (CSA) was obtained from the
simulated ﬁt of the spectra.
Fig. 1. 1H-decoupled 31P NMR powder spectra of MLV samples of POPC control (solid
line), POPC with 4 mol% WT-PLB (dotted line), POPC with 4 mol% P-PLB (dashed
line) and POPC with 4 mol% R9C-PLB (dotted-dashed line).
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tions including the long axis of rotation and lipid diffusion upon protein
interaction [49]. Fig. 2 shows the 31P T1 values ofMLVs of POPCwith and
without 4 mol% WT-PLB, P-PLB and R9C-PLB as a function of tempera-
ture. At 25 °C, the 31P T1 values of the lipids with and without
WT-PLB, P-PLB and R9C-PLB are similar. As the temperature increases
from 25 °C to 55 °C, the 31P T1 values of the POPC lipid control increase
(Fig. 2, crosses). The addition of 4 mol% WT-PLB decreases the 31P T1
values dramatically and the reduction is more pronounced as the tem-
perature increases. P-PLB and R9C-PLB also decrease the 31P T1 values,
but to a lesser extent when compared to WT-PLB.Fig. 2. 31P T1 of MLV samples of POPC control (crosses), POPC with 4 mol% WT-PLB
(open circles), POPC with 4 mol% P-PLB (open triangles) and POPC with 4 mol%
R9C-PLB (solid squares) at 25 °C, 35 °C, 45 °C and 55 °C. The error bars were obtained
by averaging 31P T1 values from multiple different sample sets.3.2. 2H NMR spectroscopy of WT-PLB, P-PLB and R9C-PLB in phospholipid
bilayers
Fig. 3 shows 2H NMR spectra of MLVs of POPC with and without
4 mol%WT-PLB, P-PLB and R9C-PLB. From Fig. 3, the control POPC lipids
give the largest quadrupolar splittings (Fig. 3, solid line) and the addi-
tion ofWT-PLB, P-PLB and R9C-PLBdecreases the quadrupolar splittings
(Fig. 3). P-PLB and R9C-PLB have a smaller and similar reduction in
quadrupolar splittings than WT-PLB. Fig. 4 shows the calculated 2H
SCD order parameters of the POPC acyl chains with and without
4 mol%WT-PLB, P-PLB and R9C-PLB. Quadrupolar splittings of dePaked
2H NMR spectra reveal the corresponding order parameters of the C–D
methylene groups and the terminal methyl groups of the lipid acyl
chain [39–41]. The quadrupolar splitting of the CD3 methyl groups at
the end of the acyl chains is the smallest and closest to 0 kHz since
they are less restricted than the ones near the membrane surface
[39–41]. The next smallest quadrupolar splitting is the 2H attached to
C-14 and so forth along the acyl chain. The POPC control sample has
the largest order parameters among the four samples along the entire
acyl chain (Fig. 4). Decreasing order parameters indicate increased dy-
namic motion [39–41]. The 4 mol%WT-PLB decreases the SCD order pa-
rameters of 2H along the lipid acyl chain dramatically (Fig. 4, open
circles). This indicates a strong interaction between WT-PLB and the
membrane hydrophobic region. P-PLB (Fig. 4, open triangles) and
R9C-PLB (Fig. 4, solid squares) induce less order parameter reductions
than WT-PLB and the order parameters are similar for both of them
along the acyl chain. For all three types of PLB, a more pronounced re-
duction in SCD order parameters is observed for the 2H near the mem-
brane surface than the ones in the hydrophobic core. Both P-PLB and
R9C-PLB have subtle effects on the 2H SCD order parameters in the
lipid hydrophobic core region. The data suggest that the membrane
core is less susceptible to protein interaction than the membrane
surface.
4. Discussion
It is important to study the structural and dynamic properties of
membrane proteins in their native environment. Lipid bilayers help
stabilize hydrophobic membrane proteins [50,51]. Different forms of
PLB including WT-PLB, P-PLB and mutated PLB result in various ef-
fects on SERCA. WT-PLB inhibits SERCA while P-PLB relieves the inhi-
bition [1]. Different mutated forms of PLB can either enhance or
impair the inhibition and are called gain of function mutations andFig. 3. 2H NMR spectra of MLV samples of POPC control (solid line), POPC with 4 mol%
WT-PLB (dotted line), POPC with 4 mol% P-PLB (dashed line) and POPC with 4 mol%
R9C-PLB (dotted-dashed line).
Fig. 4. Smoothed acyl chain (DMPC-d54) order parameter (SCD) calculated from the
dePaked spectra of MLV samples of POPC control (crosses), POPC with 4 mol%
WT-PLB (open circles), POPC with 4 mol% P-PLB (open triangles) and POPC with
4 mol% R9C-PLB (solid squares).
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N27A and N30C, reveals a super-inhibition effect on SERCA when
compared with WT-PLB [52,54,55]. Loss of function PLB mutants,
like R9C, cannot inhibit SERCA function as efﬁciently as WT-PLB [20].
Direct effects of mutation or phosphorylation on PLB can be investi-
gated from several different perspectives. These effects, including
changes in PLB oligomerization, conformations, interaction with mem-
brane and afﬁnity to SERCA, may lead to PLB function variations on
SERCA. Previous oligomerization studies indicate that loss of functions
mutants exist predominantly as pentamers,while somegain of function
PLBmutants existmostly in themonomeric form [49,50]. R9C-PLB has a
slightly larger pentamer population thanWT-PLB [53,54]. Oligomeriza-
tion change could partially contribute to the alterations of PLB mutant
function on SERCA. SERCA-PLB interaction studies suggest that all
WT-PLB, P-PLB and several PLB mutants have similar binding afﬁnity
to SERCA, so PLB afﬁnity to SERCA is distinct from its inhibition potency
[53]. Lipid interactionwith PLBmay partially contribute to function var-
iation according to WT-PLB and P-PLB studies. Most WT-PLB is in the
pentameric T-state with the cytoplasmic domain anchored on the
membrane surface and perturbing it signiﬁcantly [7,35]. Upon phos-
phorylation, the PLB population shifts toward an intermediate T′ state
or R statewith less perturbations on themembrane surface [17]. This in-
dicates a possible dissociation process of the P-PLB cytoplasmic domain
from the membrane surface [35,50,56]. Thus, membrane associated
WT-PLB can inhibit SERCA, while the membrane dissociated P-PLB re-
lieves the inhibition. The membrane bilayer is essential here to serve
as both a native system and a possible mediation being actively in-
volved in regulating PLB functionality. Studies focused on the interac-
tion between phospholamban and the membrane can provide insight
into the functional variation of different forms of PLB.
The interaction of R9C-PLB with the membrane is examined in this
work. 31P solid-state NMR spectra provide evidence for dynamic
changes on the membrane surface with the addition of PLB. WT-PLB
dramatically decreases the 31P CSA width, which indicates a dynamic
increase in the 31P headgroup region on the membrane surface [35].
R9C-PLB induces a moderate decrease in the CSA width, which is very
similar to the effect of P-PLB (Fig. 1). The data reveal that both
R9C-PLB and P-PLB have less association with the membrane surface
when compared with WT-PLB. Phosphorylation shifts the PLB popula-
tion from the T state to the R state or the intermediate T′ state withthe cytoplasmic domain detached or partially detached from the mem-
brane surface [13]. Like phosphorylation, the R9C mutation may also
shift PLB toward a conformation in which the cytoplasmic domain
tends to dissociate from the lipid bilayer headgroup region. This hy-
pothesis is further supported by the 31P NMR T1 relaxation data. The
31P T1 value reﬂects membrane surface and acyl chain conformation
changes, long axis rotation, and lipid diffusion upon protein interaction
[49]. At room temperature, the 31P T1 values of the POPC lipidswith and
without WT-PLB, P-PLB and R9C-PLB have no signiﬁcant difference
(Fig. 2). As the temperature increases from 25 °C to 55 °C, the T1 values
of the POPC control increases. The addition of WT-PLB, P-PLB and
R9C-PLB decreases the 31P T1 values. TheWT-PLB induces themost dra-
matic reduction in T1 while the P-PLB and R9C-PLB produce a similar
andmoderate reduction (Fig. 2). When the T1 value reaches its smallest
value, relaxation is more efﬁcient [57,58]. For the POPC lipid control
sample, the temperature with the lowest T1 value is lower than 25 °C,
which is typical for phospholipids [49,57,58]. With the addition of
WT-PLB, P-PLB or R9C-PLB, the T1 value decreases as temperature in-
creases. This indicates that the temperature at the minimal T1 value
has been shifted to above 55 °C by WT-PLB, P-PLB and R9C-PLB with
WT-PLB yielding themost pronounced effect on T1. Themembrane sur-
face is perturbedmostly by the cytoplasmic domain of PLB [6,7]. As var-
ious conformations of this region interact differently with the lipid
bilayer surface, it can potentially tune the PLB inhibitory effect [7,59].
The similarity in the data of R9C-PLB and P-PLB effect onmembrane sur-
face suggests that there is less association with the membrane surface
when compared to WT-PLB. Phosphorylation on the cytoplasmic do-
main could enhance the hydrophilicity of this region resulting in less in-
teraction with the membrane surface. For the R9C-PLB, the dissociation
could be due to the mutation of positively charged Arg into neutral Cys
eliminating the electrostatic interaction between Arg and the POPC
head group or the changes of the hydrophobicity of residue 9 [60].
The lipid-mediated dissociation observed in this study could facilitate
them adopting an inhibition removal favorable conformation.
2H quadrupolar splittings of 2H labels on the entire acyl chain of the
POPC-d31 lipids reﬂect dynamics of the lipid bilayer hydrophobic region
[34,35,42]. SCD order parameters calculated from the 2H quadrupolar
splittings yield individual 2H dynamics along the acyl chain. 2H nuclei
near the membrane surface have larger order parameters than the
ones near the membrane core since 2H nuclei near the membrane sur-
face are more restricted [41]. WT-PLB decreases SCD order parameters
to a greater extent than P-PLB and R9C-PLB on the entire acyl chain
(Fig. 4). The SCD order parameter values indicate additional interaction
of the membrane hydrophobic region with WT-PLB when compared
with P-PLB and R9C-PLB. Moderate effects of R9C-PLB on the lipid hy-
drophobic region similar to P-PLBmay relate to their inhibition relief ef-
fect on SERCA. 2H nuclei on the acyl chain near the membrane surface
region are disturbed more signiﬁcantly by PLB than the ones located
in the membrane center. In this region, the more distinct SCD values of
the lipid with the addition of WT-PLB compared with P-PLB and
R9C-PLBmay result from a domain Ib conformation change upon phos-
phorylation or R9Cmutation [61]. Interestingly, the region in the mem-
brane center is not signiﬁcantly disturbed by either R9C-PLB or P-PLB,
while WT-PLB does alter this region. The data suggest that acyl chain
dynamics in the membrane core is less susceptible to membrane pro-
tein perturbation than the region near the surface.
5. Conclusions
In conclusion, R9C-PLB function loss could be due to its oligomeriza-
tion states, structural conformations and interaction with membrane.
From a membrane perspective, similar to P-PLB, R9C-PLB has a less sig-
niﬁcant interaction with both the surface and hydrophobic regions of
the lipid bilayer when compared with WT-PLB. The less signiﬁcant dis-
turbance of R9C-PLB and P-PLB on the membrane surface may result
from the detachment or partial detachment of the cytoplasmic domain
2448 X. Yu, G.A. Lorigan / Biochimica et Biophysica Acta 1828 (2013) 2444–2449from the lipid bilayer. The membrane bilayer may act as a mediation to
regulate PLB function. Future studies can directly focus on the R9C-PLB
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